Trial Profile
Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary) ; Lomustine; Procarbazine; Vincristine
- Indications Astrocytoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- Acronyms CODEL; Codeleted
- 28 Jan 2022 According to European Clinical Trials Database, this trial has been discontinued in Austria.
- 23 Jan 2022 According to European Clinical Trials Database, this trial has been discontinued in Netherland.
- 21 Jan 2022 According to European Clinical Trials Database, this trial has been discontinued in Belgium.